ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Zynerba Pharmaceuticals Inc (ZYNE) Report Updated: May 27, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Zynerba Pharmaceuticals Inc (ZYNE)

Rating: Strong Buy Volatility: Aggressive
Total Grade: A Industry: Pharmaceuticals
Competitors: HSKA,HCM,AERI,PAHC

Stock Analysis

Rating: Monthly View

A
B
C
D
F
May June July August September October November December January February March April

Rating: Weekly View

This Week: A down upgrade
Last Week: B same downgrade
Two Weeks Ago: A up no change
service keys

Zynerba Pharmaceuticals Inc© quotemedia

Company Profile